FDA recall D-0575-2025

Pfizer · Class II · drug

Product

Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.

Reason for recall

Subpotent drug

Distribution

Within U.S

Key facts

Status: Ongoing
Initiation date: 2025-07-29
Report date: 2025-08-20
Voluntary/Mandated: Voluntary: Firm initiated
Location: Manhattan, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0575-2025